Search

Your search keyword '"Peter G, Kremsner"' showing total 843 results

Search Constraints

Start Over You searched for: Author "Peter G, Kremsner" Remove constraint Author: "Peter G, Kremsner"
843 results on '"Peter G, Kremsner"'

Search Results

1. Parasitic infections during pregnancy in Gabon affect glycosylation patterns of maternal and child antibodies

2. Resistance of Anopheles gambiae s.s. against commonly used insecticides and implication of cytochrome P450 monooxygenase in resistance to pyrethroids in Lambaréné (Gabon)

3. LC-MS based analysis reveal antimicrobial compounds from Gabonese pharmacopoeia: chemical characterisation and cytotoxicity evaluation

4. Safety and efficacy of praziquantel in pregnant women infected with Schistosoma haematobium in Lambaréné, Gabon – Clinical results from the randomized, single-blinded, controlled freeBILy-Gabon trial

5. Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malaria

6. PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adultsResearch in context

7. First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster

8. Machine learning prediction of malaria vaccine efficacy based on antibody profiles.

9. Evaluation of knowledge, attitude and practices towards loiasis in the rural community of Sindara, in central African Gabon.

10. Emergence of Novel Norovirus GII.4 Variant

11. Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries

12. Anopheles gambiae s.s. resistance to pyrethroids and DDT in semi-urban and rural areas of the Moyen-Ogooué Province, Gabon

13. Gut microbiota in vaccine naïve Gabonese children with rotavirus A gastroenteritis

14. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

15. Making clinical trials a public norm for health decisions in sub-Saharan Africa

16. Markers of prolonged hospitalisation in severe dengue.

17. Sporozoite immunization: Innovative Translational Science to Support the Fight against malaria

18. Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP

19. Mucosal response of inactivated and recombinant COVID‐19 vaccines in Congolese individuals

20. Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies

21. RT-PCR-based assessment of the SD Bioline Rota/Adeno Antigen-based test in infants with and without diarrhea

22. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma

23. Tübingen model study: large-scale introduction of rapid antigen testing in the population and the viral dynamics of SARS-CoV-2

24. Assessing the Incidence of Snakebites in Rural Gabon—A Community-Based, Cross-Sectional Pilot Survey

26. Aetiologies and clinical presentation of central nervous system infections in Vietnamese patients: a prospective study

27. Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19

28. Diagnosis of pathogens causing bacterial meningitis using Nanopore sequencing in a resource-limited setting

29. Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon

30. A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection

31. Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial

32. Assessment of malaria transmission intensity and insecticide resistance mechanisms in three rural areas of the Moyen Ogooué Province of Gabon

33. Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa

34. Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens

35. Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

36. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity

37. Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.

38. Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy

39. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients

40. Establishing a controlled hookworm human infection (CHHI) model for Africa: A report from the stakeholders meeting held in Lambaréné, Gabon, November 10–11, 2019

41. Complementary methods for SARS-CoV-2 diagnosis in times of material shortage

42. COVID-19 and syndemic challenges in ‘Battling the Big Three’: HIV, TB and malaria

43. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

44. A call to caution when hydroxychloroquine is given to elderly patients with COVID-19

45. Genomic surveillance of SARS-CoV-2 in the Republic of Congo

46. Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression

47. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

48. Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa

50. How to (ab)use a COVID-19 antigen rapid test with soft drinks?

Catalog

Books, media, physical & digital resources